Metraipolis › archive › dc_4950d669f9bf

Pharmacoeconomic evaluation of weight-based vs fixed-dose pembrolizumab for non-small cell lung cancer in China — Europe PMC PMID:41169376

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41169376
DOI
10.3389/fimmu.2025.1665469
License (as archived)
solo-consultazione
Archived
2026-10-08T15:31:38.883Z
SHA-256 of the archived text
63fbc61ff5e7ddbd377b82bfe0cdbcb14f18f0dc8ffa5712e25cf47e263ffa6c
Stable URL of this page
https://metraipolis.com/documento/dc_4950d669f9bf

How to cite

Pharmacoeconomic evaluation of weight-based vs fixed-dose pembrolizumab for non-small cell lung cancer in China — Europe PMC PMID:41169376 — Europe PMC (en), https://europepmc.org/article/MED/41169376 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4950d669f9bf (Metraipolis archive dc_4950d669f9bf, sha256 63fbc61ff5e7ddbd377b82bfe0cdbcb14f18f0dc8ffa5712e25cf47e263ffa6c)
BibTeX
@misc{dc4950d669f9bf,
  title = {Pharmacoeconomic evaluation of weight-based vs fixed-dose pembrolizumab for non-small cell lung cancer in China — Europe PMC PMID:41169376},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41169376},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4950d669f9bf; sha256 63fbc61ff5e7ddbd377b82bfe0cdbcb14f18f0dc8ffa5712e25cf47e263ffa6c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41169376. Agents can read the archived copy with the MCP tool read_document.